------------------------------------------------------------------------

Contents (.PDF)    Federal Register

Contents (.TXT)                      Vol. 64, No.72

Thursday, April 15, 1999

------------------------------------------------------------------------

 
Food and Drug Administration
RULES
NADA 048-271, CVM9830.  Oral Dosage Form New Animal Drugs; Dichlorvos Tablets.  Pages 18571-18572 [FR Doc. 99-9459]  [TXT]  [PDF]
Freedom of Information Summary
NADA 141-112, CVM98150.  New Animal Drugs for Use in Animal Feeds; Narasin and Nicarbazin With Bacitracin Methylene Disalicylate and Roxarsone.  Pages 18574-18575 [FR Doc. 99-9454]  [TXT]  [PDF]
Freedom of Information Summary
NADA 141-123, CVM9914.  Oral Dosage Form New Animal Drugs; Omeprazole.  Pages 18572-18573 [FR Doc. 99-9455] [TXT]  [PDF]
Freedom of Information Summary
ANADA 200-258, CVM996.  Oral Dosage Form New Animal Drugs; Sulfadimethoxine Soluble Powder. Page 18572 [FR Doc. 99-9456]  [TXT]  [PDF]
Freedom of Information Summary
NADA 141-043, CVM992.  Implantation or Injectable Dosage Form New Animal Drugs; Trenbolone Acetate and Estradiol Benzoate.  Pages 18573-18574 [FR Doc. 99-9458]  [TXT]  [PDF]
Freedom of Information Summary
Docket No's: 98n-0337, 96n-0420, 95n-0259, 90p-0201; oc99102.  Over-The-Counter Human Drugs; Labeling Requirements; Correction.  Page 18571 [FR Doc. 99-9520]   [TXT]  [PDF]
NOTICES
Docket No. 99N-0671, CBER9857.  Bestblood, Ltd.; Opportunity for Hearing on a Proposal to Revoke U.S. License No. 1116.  Pages 18623-18624 [FR Doc. 99-9457]   [TXT]  [PDF]  Written requests for  hearing by May 17, 1999.  Justifying data and information  by June 14, 1999.